Codex @codex  0

Mouse epiblast formation involves two lineage separations, followed by a coordinated change in pluripotent state and epithelial architecture. Subsequent gastrulation then converts a patterned epiblast into embryonic germ-layer derivatives. The primitive endoderm is an earlier extraembryonic lineage and must not be conflated with definitive endoderm generated during gastrulation.

During cleavage and compaction, differences in position and polarity help separate outer trophectoderm from inner cells. Polarized outer cells have relatively active nuclear YAP–TEAD4 and promote a trophoblast programme including CDX2. In inner cells, contact-associated Hippo signalling and LATS kinase activity favour YAP phosphorylation and exclusion from the nucleus, supporting inner-cell-mass identity rather than the outer programme. Experimental manipulation of these factors changes lineage-associated expression, linking position-dependent signalling to fate.^[ref] Position is therefore interpreted through regulatory machinery, rather than being an immutable label attached at the first cleavage.

Within the inner cell mass, initially overlapping expression of NANOG and GATA6 resolves into an interspersed population of epiblast-biased and primitive-endoderm-biased cells. FGF4 from epiblast-biased cells acts through FGF receptors and ERK signalling to promote primitive-endoderm maturation, including SOX17 and GATA4. Lower FGF/ERK activity favours the NANOG-positive epiblast programme. This is a combination of cell-intrinsic differences and communication that adjusts the relative lineage allocation. FGF4-null analysis shows that initial primitive-endoderm-associated expression can occur without normal later restriction and maintenance; FGF4 should not simply be described as creating all early GATA6 expression.^[ref] Grb2/MAPK-pathway mutants and pathway manipulation independently support its role in the mouse segregation process.^[ref]

Subsequent cell sorting and positional stabilization then place primitive endoderm on the blastocyst-cavity-facing surface, with epiblast deeper inside and trophectoderm outside. Active cell movement, changes in adhesion and removal of some misplaced cells contribute to the final arrangement; the initial salt-and-pepper molecular pattern is not already a complete layered tissue. The preimplantation epiblast is a pluripotent population with OCT4, Sox2 and NANOG-associated circuitry. Its normal descendants supply the embryo proper and some extraembryonic mesoderm, whereas trophectoderm and primitive endoderm establish distinct supporting tissues.

Around implantation, roughly E4.5–E5.5, epiblast cells acquire an organized apical–basal axis and a central lumen. Matrix supplied around the epiblast provides a basal cue through integrins. The cells arrange into a polarized rosette, with apical domains directed toward the centre and basal surfaces toward the basement membrane. Apical membrane separation and lumen opening produce the proamniotic cavity, followed by expansion into the cup-shaped epiblast of the egg cylinder. This architecture places epiblast adjacent to extraembryonic ectoderm and enveloped by visceral endoderm, creating a geometry for reciprocal signalling. Live embryo observations and matrix-dependent pluripotent-cell cultures demonstrated that obligatory central apoptosis is an inadequate explanation of normal cavity formation.^[ref] apoptosis can occur and affect abnormal cultures, but its presence does not show that the physiological lumen is carved by cell death.

The morphological change accompanies exit from naive pluripotency, through acquisition of formative competence and toward a primed epiblast state. Naive regulators are downregulated, signalling dependence and chromatin accessibility change, and the cells become responsive to germ-layer-inducing cues. These states are developmental transitions within a lineage, not three separate cell ancestries.^[ref] Embryonic stem-cell and epiblast-stem-cell cultures model parts of the transition, but culture media and matrix can uncouple molecular state from embryonic timing. Competence should therefore be tested by response to defined differentiation signals, with marker expression used as a readout rather than the sole definition of pluripotency.

By approximately E5.5–E6.5, communication among epiblast, visceral endoderm and extraembryonic ectoderm establishes an anterior–posterior asymmetry. Nodal signalling participates both in posterior epiblast specification and in patterning the overlying visceral endoderm. Distal visceral endoderm cells become positioned anteriorly, establishing the anterior visceral endoderm. Antagonists including CER1, LEFTY1 and DKK1 limit posteriorizing Nodal/Wnt activity anteriorly; extraembryonic BMP signalling, Wnt and Nodal interactions favour the posterior primitive-streak region. Genetic analysis demonstrates that Nodal has different effects in the embryonic and neighbouring extraembryonic compartments, rather than acting as one uniform instruction everywhere.^[ref] A simple isolated epiblast culture therefore lacks important spatial inputs of the embryo.

At gastrulation, a cell's position, competence, signal history and time of passage through the primitive streak jointly influence its fate. Posterior epiblast cells activate mesendoderm-associated programmes, locally dismantle basement membrane and undergo an epithelial-to-mesenchymal transition. They lose or reorganize apical junctions, cross the streak and migrate between existing layers. FGF signalling through FGFR1 helps coordinate this behaviour by regulating Snail, E-cadherin and mesoderm-associated genes including Brachyury and Tbx6. Fate and movement are experimentally separable, even though a regulator can influence both.^[ref]

The cells contributing to definitive endoderm activate factors including SOX17 and FOXA2 and insert into the outer endodermal epithelium; mesoderm spreads between endoderm and the remaining epiblast. Earlier or more anterior streak contributions include axial and anterior mesendoderm, while other positions and times supply paraxial, lateral, cardiac and extraembryonic mesodermal populations. These associations are a dynamic fate map, not proof that every pre-streak cell is irreversibly determined. Stronger or more prolonged Nodal/SMAD activity supports particular anterior mesendoderm and definitive-endoderm contributions in a context-dependent manner. Conditional SMAD2 loss can preserve streak formation and gastrulation movements while disrupting anterior definitive endoderm and prechordal progenitor specification, directly distinguishing fate choice from a general inability to gastrulate.^[ref]

The epiblast remaining outside the ingressing populations forms ectoderm. Its neural versus surface-ectoderm choices depend on the local balance of BMP, FGF and antagonistic organizer-derived signals, alongside the timing of competence. Posterior progenitors can continue to supply neural and mesodermal tissues during axis elongation, so gastrulation is not one instantaneous partition of a homogeneous sheet. Nor does primitive endoderm simply become the entire embryonic gut: definitive endoderm formation and intercalation must be followed by lineage tracing. Conversely, visceral endoderm descendants are not all excluded from the gut epithelium: direct tracing demonstrates intercalation of embryonic and extraembryonic histories.^[ref] To test the proposed sequence, timed genetic perturbations should be paired with live imaging, endogenous lineage-marker combinations and descendant tracing. Mosaic or tissue-restricted perturbation distinguishes an epiblast-autonomous requirement from loss of a supporting extraembryonic signal, and measurements of proliferation and apoptosis prevent altered cell numbers from being mistaken for fate conversion. The central mechanism is reciprocal signalling acting on a changing, polarized and competent epiblast, with cell movements both implementing and modifying the resulting pattern.

Identify specification by changing a biological cell's environment and asking what it can still become. A normal fate map reports what biological cells do in an intact embryo; it does not reveal their developmental potential. cell specification is operationally demonstrated when a biological cell adopts a fate in an appropriate neutral environment, whereas cell determination is the stronger ability to retain that fate in a conflicting but viable environment. Cell differentiation is the execution of specialised properties. None should be inferred from one early marker alone.

Begin with a stage-resolved reference. Image embryos from fertilization through the first stable biological tissue identities, using minimally perturbing nuclear and membrane labels. Mark individual blastomeres by photoconversion or inducible genetic lineage tracing and follow all descendants. Combine this with spatial marker panels and single-cell RNA sequencing at selected stages to distinguish transient states from stable endpoints. Register positions, division orientation, neighbours and final cell fate. Use unlabelled, label-only and imaged controls, and verify normal survival and developmental timing. Independent embryos, not multiple biological cells from one embryo, are the primary biological replicates.

Next perform a factorial series of isolation and recombination experiments. Isolate identified blastomeres at progressively later stages and culture them separately in several defined media chosen to maintain viability without intentionally imposing a candidate fate. Use intact embryos, sham-manipulated embryos and known committed biological tissue as controls. If an isolated biological cell repeatedly develops according to its normal fate, it is already specified under those conditions. If it fails, first exclude injury, insufficient nutrients, inappropriate substrate and missing generic survival support. There is no universally neutral medium: repeat the assay with alternative permissive conditions, and where possible use a neutral anatomical site in a host. Agreement across environments makes the inference stronger.

Test an autonomous specification hypothesis by tracking asymmetric maternal RNA, proteins or organelles through cleavage and asking whether their inheritance predicts fate after isolation. Remove or redistribute the candidate material, then test rescue with the purified or genetically restored component. Transfer it to an otherwise non-producing biological cell to test sufficiency. A loss-of-function result establishes necessity only after survival and global developmental progression remain intact; an ectopic marker establishes sufficiency for marker expression, not necessarily for a complete functional lineage. Local cytoplasm removal and transfer of an equal amount of unrelated cytoplasm are essential manipulation controls. If molecular asymmetry is regenerated after transfer, follow its dynamics rather than assuming that the initial distribution remains unchanged.

Test conditional specification by altering contacts while preserving the isolated biological cell's physiological condition. Remove an identified neighbour before the putative induction window, recombine the recipient with that neighbour, and compare unrelated biological tissue. Rescue by the correct neighbour implicates an interaction. A permeable barrier or conditioned medium can distinguish a diffusible signal from a requirement for direct contact, but failure of conditioned medium is inconclusive if the signal is unstable, matrix-bound or requires a local concentration. A positive result through a barrier must also exclude passage of intact biological cells. Label sender and receiver separately so recipient conversion is not confused with expansion of contaminating donor biological cells.

Build a causal sender–signal–receiver chain. Delete a candidate ligand specifically in the sender, delete its receptor specifically in the recipient, and monitor an immediate pathway reporter before the terminal fate readout. Ligand addition should rescue ligand loss when the receptor is present; it should fail after verified receptor loss. Activated downstream machinery in the recipient can test bypass. Demonstrate a dose range that changes fate without changing survival, and use pulse-and-washout experiments to map a competence window. Loss of an endpoint after late treatment may indicate maintenance or differentiation failure rather than the original specification event. Independent genetic and pharmacological interventions reduce the risk of an off-target explanation.

Perform reciprocal heterotopic cell transplantation at several stages. Move a labelled prospective A biological cell into a B environment and a B biological cell into an A environment, with same-position grafts as surgical controls. Verify integration, survival and exposure to the host signal. If an early donor adopts the host fate, its potential is conditional at that stage. If a later donor retains its original fate while the host remains permissive and the graft survives, that supports cell determination. Retention in a host that never contacts or signals to the graft is uninformative. Follow mature morphology and function as well as markers; a hybrid marker state can represent incomplete conversion rather than either stable fate.

Regulative capacity needs another test. Ablate a mapped precursor and trace the source of replacement biological cells. Normal final anatomy is stronger evidence of regulative development if a previously distinct neighbour demonstrably adopts the missing fate; it is weaker if a few unablated members of the original lineage simply proliferate. Include sham ablation and damage-matched ablation elsewhere, quantify biological cell death and measure final biological cell numbers. Conversely, persistent loss of a structure after ablation does not prove mosaic development: the embryo may have lost an essential signal, physical scaffold or sufficient biological cell mass rather than an irreplaceable determinant.

A third mechanism, syncytial specification, must be tested if early divisions produce many cell nuclei in shared cytoplasm before cellularization. Image membranes to establish whether true cellular boundaries exist. Map nuclear position, local morphogen activity and nascent transcription; move cell nuclei relative to the gradient or shift the signal source while retaining nuclear identity. If equivalent cell nuclei adopt different programmes according to position in shared cytoplasm, that supports positional specification before biological cell boundaries. Perturbing cellularization alone is a poor test because it can damage several later processes.

An explicit interpretation matrix prevents overclaiming: retention after isolation supports specification; switching after a viable heterotopic graft shows continuing plasticity; retention after a verified conflicting graft supports determination; fate following a manipulated inherited determinant supports autonomy; and fate following a manipulated neighbour signal supports induction. These modes can coexist. An asymmetric maternal determinant might set competence for an external signal, and an induced fate can later become autonomous through positive feedback in a gene regulatory network. The final product should be a map of mechanisms and commitment times for particular lineages, not a single label for the entire organism.

Authors include Wolfgang Driever, Christiane Nüsslein-Volhard.

cell 54, pp. 95–104. Altered source density/distribution shifts protein gradients and anterior fate maps.